|
|
发表于 2009-9-29 02:32 PM
|
显示全部楼层
What do you think about this? Is H1N1 still going to be a big issue in China this year? I thought it was over...
Hard to Treat Diseases (HTDS) obtains H1N1 license with China SFDA
SHENZHEN, China, Sept. 29 /PRNewswire-FirstCall/ - HTDS www.htdsmedical.com
(HTDS) The issuer's China based operating subsidiary Mellow Hope
through its exclusive business partner Zhejiang Tianyuan Bio-
pharmaceutical Co., Ltd has been granted H1N1 license on September 24,
2009 by SFDA (China Authority) http://eng.sfda.gov.cn/eng. Mellow Hope
is the exclusive agent of Zhejiang Tianyuan Bio-pharmaceutical Co.,
Ltd for International marketing and sales
Today, the issuer completed a set of filings in both Chinese and
English translations on Pink Sheets www.pinksheets.com see filing
titled "Supplemental Information - H1N1 License and Supporting
Documents" or this direct link http://www.pinksheets.com/pink/quote/quote.jsp?symbol=htds.
Also, the company promised in two separate news releases of September
2009 that it will release the name of its exclusive partnership. The
filings and supporting H1N1 documents on Pink Sheets are self
explanatory.
The company believes that there is a naked short interest in the stock
and the company has retained counsel to investigate this matter and
possible market manipulation by short sellers. In this connection, the
Company has received numerous allegations and complaints from
shareholders. In addition, the company has been the victim of
anonymous "stock bashing" and a campaign of negative publicity, a
smear campaign. In fact, there is a lawsuit in progress on some of
these issues.
"We believe that the full potential of our H1N1 vaccine business has
yet to be realized in our stock price and this report outlines some of
the issues involved," said HTDS CEO Terry Yuan. "Take a good look at
all that is going on now for HTDS and you may be surprised to find
that when you do so, you share our enthusiasm for HTDS. H1N1 is done
and completed so we are eager to start to profit from this huge demand
from customers who want to now buy HTDS products immediately. We are
also moving with great energy to get our audits completed and get
OTCBB listed. When you look at the potential cancer and anti-aging
projects of Slavica Bio Chem it is easy to find yourself strongly
visualizing their enormous potential. HTDS is also taking aggressive
action against the suspected naked shorting that has apparently
affected our stock so we can remove all possible barriers to
appreciation and give our investors confidence in the future of their
investment. Further, most people do not seem to realize we have
recently made a sizable recent reduction in our stock outstanding and
understand fully what that means. When you add all the excitement all
this has created to our eagerness to move forward, it can cause you to
start to see that we are on verge of a major expansion. We believe you
have to find yourself putting HTDS in that spot in your mind where you
would put a company that has virtually unlimited upside. We look
forward to the future and we believe that a year from now we will find
ourselves looking back on back on this time as one where we all
participated in a major expansion." |
|
狗仔卡